Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 1:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1801–1824 of 3,875 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: fast Clear all

Conditions: Epilepsy, Migraine, Headache, Pain, Autism, Cerebral Palsy, Brain Development, Traumatic Brain Injury, ADHD - Attention Deficit Disorder With Hyperactivity, Mental Health
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Day to 69 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Immune Surveillance
Interventions: Transfer factor from colostrum ultrafiltrate; Dietary Supplement
Lead sponsor: Natural Immune Systems Inc; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Klamath Falls, Oregon

Conditions: Chlamydia, Gonorrhea, HIV
Interventions: HIV testing, STI/HIV-T, STI/HIV-Plus; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 14 Years to 21 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Infection, Human Immunodeficiency Virus
Interventions: GSK2838232 PIB (SDD), GSK2838232 PIB (API), Placebo, Ritonavir; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: SARS CoV 2 Infection
Interventions: Testing for SARS CoV2 Antigen; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 99 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Transient Ischemic Attack, Stroke
Interventions: Aspirin, Clopidogrel, Simvastatin; Drug
Lead sponsor: University of Calgary; Other
Eligibility: 40 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy
Interventions: Milvexian; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Healthy
Interventions: Olmesartan Medoxomil Tablets 40 mg, Benicar® Tablets 40 mg; Drug
Lead sponsor: Mylan Pharmaceuticals Inc; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Hip Fracture
Interventions: PUSH, Protein, Nutrition; Behavioral · Dietary Supplement
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Baltimore, Maryland • Towson, Maryland

Conditions: Healthy
Interventions: Quinapril Hydrochloride Tablets 40 mg, Accupril® Tablets 40 mg; Drug
Lead sponsor: Mylan Pharmaceuticals Inc; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2003
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Diabetes Mellitus, Type 2
Interventions: placebo for mitiglinide, mitiglinide; Drug
Lead sponsor: Elixir Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 367 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 57
States / cities: Glendale, Arizona • Greenbrae, California • La Jolla, California + 54 more

Conditions: Soft Tissue Injuries
Interventions: RF and PEMF, Ultrasound; Device
Lead sponsor: Venus Concept; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Macular Degeneration, Central Visual Impairment
Interventions: Personalised Remapping Training, RSVP personalized remappi, Reading text in the wild with remapping; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 16 Years and older
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Edina, Minnesota

Conditions: COVID, Trauma, Ultrasound
Interventions: Ultrasound lung imaging as part of FAST+ evaluation; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: Not listed
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Coronary Artery Disease
Interventions: FMD Arm; Dietary Supplement
Lead sponsor: Hypertension Institute, Nashville; Other
Eligibility: 35 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obesity, Overweight, Overnutrition, Nutrition Disorders, Signs and Symptoms
Interventions: Intervention Program; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 21 Years and older
Enrollment: 443 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obesity
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Diabetes Mellitus
Interventions: Patient Relationship Management (PRM) Program; Behavioral
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 76 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Healthy
Interventions: Oxycodone HCl 5 mg / Ibuprofen 400 mg tablets, single dose, COMBONOX® tablets, single dose; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: HIV Infections
Interventions: HIV Test Offer, General Health Screen Offer; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Heart Diseases, Diabetes, Obesity
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 50 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy Volunteers
Interventions: MLN3126, MLN3126 Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Eatontown, New Jersey

Conditions: Healthy Subjects
Interventions: Paracetamol fast dissolution suspension, Paracetamol medium dissolution suspension, Paracetamol slow dissolution suspension, Paracetamol; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 19 Years to 50 Years · Male only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Prostate Cancer
Interventions: ARN-509 (Phase 1), ARN-509 (Phase 2); Drug
Lead sponsor: Aragon Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 15
States / cities: San Diego, California • San Francisco, California • Atlanta, Georgia + 12 more

Search by objective public record fields.

Clinical Applications of High-Frequency Oscillations

Clinical Proof-of-concept Study on Rapid Immune Modulating Effects

Project AWARE: Using the Emergency Department (ED) to Prevent Sexually Transmitted Infections (STIs) in Youth

A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Rutgers Pilot for PREDICT- Patient POC Test

Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)

A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants

Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

PUSH Plus Protein Pilot for Hip Fracture Patients

Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

RF/PEMF Versus Ultrasound for the Treatment of Soft Tissue Injury

Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss

The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation

Evaluation of a Fasting Mimicking Diet

Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care

Effects of Diet Changes on Metabolism

Chronic Care Management/Patient Relationship Management Proof of Concept

A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions

The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies

Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers

MLN3126 Single Rising Dose Study

A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)